Emerald Advisers, LLC Moderna, Inc. Transaction History

Emerald Advisers, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$101.21 - $166.61 $148,171 - $243,917	-1,464 Reduced 45.75%	1,736 $206,000
Q1 2024 May 08, 2024	SELL	$85.37 - $115.44 $165,276 - $223,491	-1,936 Reduced 37.69%	3,200 $340,000
Q4 2023 Feb 05, 2024	BUY	$69.51 - $104.43 $181,768 - $273,084	2,615 Added 103.73%	5,136 $510,000
Q3 2023 Oct 26, 2023	BUY	$96.41 - $126.61 $243,049 - $319,183	2,521 New	2,521 $260,000
Q2 2021 Jul 29, 2021	SELL	$129.91 - $234.98 $785,435 - $1.42 Million	-6,046 Closed	0 $0
Q1 2021 Apr 29, 2021	BUY	$109.18 - $185.98 $75,334 - $128,326	690 Added 12.88%	6,046 $792,000
Q4 2020 Jan 29, 2021	SELL	$65.74 - $169.86 $121,356 - $313,561	-1,846 Reduced 25.63%	5,356 $560,000
Q3 2020 Oct 28, 2020	BUY	$54.34 - $94.85 $112,592 - $196,529	2,072 Added 40.39%	7,202 $510,000
Q2 2020 Jul 28, 2020	BUY	$29.67 - $80.0 $152,207 - $410,400	5,130 New	5,130 $329,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Emerald Advisers, LLC with notifications on news.